DESCRIPTION (Adapted from the Applicant's Abstract): The investigator
proposes to test the hypothesis that binding of CD40L on activated T cells
to CD40+ on infected epithelial cells contributes to immunity against
Cryptosporidium parvum (Cp) in the biliary tree and the intestine. The
investigator proposes to investigate the mechanisms by which CD40-CD40L
interactions contribute to Cp immunity by determining whether: 1. CD40L
is required for the afferent or efferent limb of Cp specific immunity by
transfers of Cp immune and non-immune cells into Cp infected MHC matched
knockout recipients. 2. The intact genes for gamma-IFN, TNFR, and/or IL
12 are required for sclerosis of bile ducts in Cp infected mice. 3. The
synthesis of Bcl-series proteins is inhibited on a cell-specific basis by
Cp infection. If the investigator shows that Cp can be eliminated from
the biliary tree by non-specific as well as specific T-cell mediated
responses, a subsequent clinical study in AIDS patients, using
discriminant analysis, would be planned.
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
041096314
UEI
MW8JHK6ZYEX8
Project Start Date
01-July-1998
Project End Date
30-June-2001
Budget Start Date
01-July-1998
Budget End Date
30-June-1999
Project Funding Information for 1998
Total Funding
$138,780
Direct Costs
$91,907
Indirect Costs
$46,873
Year
Funding IC
FY Total Cost by IC
1998
National Institute of Allergy and Infectious Diseases
$138,780
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01AI040870-01A2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01AI040870-01A2
Patents
No Patents information available for 1R01AI040870-01A2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01AI040870-01A2
Clinical Studies
No Clinical Studies information available for 1R01AI040870-01A2
News and More
Related News Releases
No news release information available for 1R01AI040870-01A2
History
No Historical information available for 1R01AI040870-01A2
Similar Projects
No Similar Projects information available for 1R01AI040870-01A2